{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:04:25Z","timestamp":1787843065357,"version":"build-2784847793"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,29]]},"DOI":"10.7759\/cureus.27439","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T13:26:46Z","timestamp":1659101206000},"source":"Crossref","is-referenced-by-count":6,"title":["Generalized Granuloma Annulare Associated With Dupilumab Therapy"],"prefix":"10.7759","author":[{"given":"Kendall","family":"Phelps-Polirer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bailey L","family":"Alkhatib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.10.010","article-title":"Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis","volume":"70","author":"Eichenfield LF","year":"2014","unstructured":"Eichenfield LF, Tom WL, Chamlin SL, et al.. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol. 2014, 70:338-51. 10.1016\/j.jaad.2013.10.010","journal-title":"J Am Acad Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2021.01.020","article-title":"Remission of severe atopic dermatitis with dupilumab and rescue tofacitinib therapy","volume":"10","author":"Peterson DM","year":"2021","unstructured":"Peterson DM, Vesely MD. Remission of severe atopic dermatitis with dupilumab and rescue tofacitinib therapy. JAAD Case Rep. 2021, 10:4-7. 10.1016\/j.jdcr.2021.01.020","journal-title":"JAAD Case Rep"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-021-00266-6","article-title":"Atopic dermatitis: an expanding therapeutic pipeline for a complex disease","volume":"21","author":"Bieber T","year":"2022","unstructured":"Bieber T. Atopic dermatitis: an expanding therapeutic pipeline for a complex disease. Nat Rev Drug Discov. 2022, 21:21-40. 10.1038\/s41573-021-00266-6","journal-title":"Nat Rev Drug Discov"},{"key":"ref4","unstructured":"Dupixant [package insert]. (2017). Accessed. July 14, 2022: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/761055lbl.pdf."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2009.21.2.113","article-title":"Clinical and pathological features of generalized granuloma annulare with their correlation: a retrospective multicenter study in Korea","volume":"21","author":"Yun JH","year":"2009","unstructured":"Yun JH, Lee JY, Kim MK, et al.. Clinical and pathological features of generalized granuloma annulare with their correlation: a retrospective multicenter study in Korea. Ann Dermatol. 2009, 21:113-9. 10.5021\/ad.2009.21.2.113","journal-title":"Ann Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.06.135","article-title":"Demographic and histopathologic features of cutaneous granulomatous diseases","volume":"85","author":"Mangold AR","year":"2021","unstructured":"Mangold AR, Brumfiel CM, Patel MH, et al.. Demographic and histopathologic features of cutaneous granulomatous diseases. J Am Acad Dermatol. 2021, 85:AB27. 10.1016\/j.jaad.2021.06.135","journal-title":"J Am Acad Dermatol"},{"key":"ref7","article-title":"Diagnosis and management of granuloma annulare","volume":"74","author":"Cyr PR","year":"2006","unstructured":"Cyr PR. Diagnosis and management of granuloma annulare. Am Fam Physician. 2006, 74:1729-34.","journal-title":"Am Fam Physician"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2020.04.040","article-title":"Delayed granulomatous eruption of the nose associated with ruxolitinib","volume":"6","author":"Brown M","year":"2020","unstructured":"Brown M, Smith K, Osswald S. Delayed granulomatous eruption of the nose associated with ruxolitinib. JAAD Case Rep. 2020, 6:646-9. 10.1016\/j.jdcr.2020.04.040","journal-title":"JAAD Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.1998.tb01693.x","article-title":"The interstitial granulomatous drug reaction: a distinctive clinical and pathological entity","volume":"25","author":"Magro CM","year":"1998","unstructured":"Magro CM, Crowson AN, Schapiro BL. The interstitial granulomatous drug reaction: a distinctive clinical and pathological entity. J Cutan Pathol. 1998, 25:72-8. 10.1111\/j.1600-0560.1998.tb01693.x","journal-title":"J Cutan Pathol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/106215-generalized-granuloma-annulare-associated-with-dupilumab-therapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:47:11Z","timestamp":1707508031000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/106215-generalized-granuloma-annulare-associated-with-dupilumab-therapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,29]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.27439","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7,29]]}}}